Isothermal Nucleic Acid Amplification Technology 2022 Global INAAT Industry Key Companies - Abbott Laboratories, bioMérieux SA, Becton, Dickinson and Company Market Analysis And Forecast To 2027

According to IMARC Group latest published report, titled "Isothermal Nucleic Acid Amplification Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," that the global isothermal nucleic acid amplification technology market size reached a value of US$ 2.4 Billion in 2021. Looking forward, the market expected to reach US$ 4.9 Billion by 2027, exhibiting at a CAGR of 12.7% during 2022-2027.

Isothermal nucleic acid amplification technology (INAAT) is primarily deployed in the field of molecular biology for identifying and analyzing nucleic acids. It is majorly used for DNA, RNA, cell protein, ions, molecules, etc. Isothermal nucleic acid amplification technology (INAAT) is primarily deployed in the field of molecular biology for identifying and analyzing nucleic acids. It is majorly used for DNA, RNA, cell protein, ions, molecules, etc.

INAAT offers a rapid, sensitive, and accurate diagnosis of genetic as well as infectious ailments. It provides amplicons for producing various nucleic acids that are predominantly utilized in biosensing, bioimaging, and biomedicines. Furthermore, INAAT is also used for detecting several diseases, such as influenza, HIV, tuberculosis, chlamydia, and gonorrhea (CT/NG), Hepatitis A and B, etc. Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report,

Covid-19 Scenario:

Note: We are regularly tracking the impact of COVID-19 on the Isothermal Nucleic Acid Amplification Technology market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/isothermal-nucleic-acid-amplification-technology-market/requestsample

Isothermal Nucleic Acid Amplification Technology Market Trends:

The widespread of COVID-19 has led to the rapid shift from specialized laboratory equipment towards INAAT for coronavirus detection. Additionally, the high prevalence of several chronic diseases has augmented the demand for effective diagnosis and treatment procedures, which is propelling the market growth. The increasing popularity of INAAT in identifying genetically modified organisms (GMOs) is also catalyzing the market. Several technological advancements in the sector have led to the development of Recombinase Polymerase Amplification (RPA), Single Primer Isothermal Amplification (SPIA), and Strand Displacement Amplification (SDA). The rising investments in various R&D activities are anticipated to bolster the market for INAAT in the coming years.

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of the key players being Abbott Laboratories (NYSE: ABT), BIOMERIEUX (BIM.PA), BD (Becton, Dickinson and Company), Eiken Chemical Co. Ltd., Hologic Inc., Meridian Bioscience Inc., OptiGene Limited, Thermo Fisher Scientific Inc., Tecan Trading AG, Ustar Biotechnologies Ltd., etc.

Ask Analyst for 10% free customized report: https://www.imarcgroup.com/isothermal-nucleic-acid-amplification-technology-market

The report cover the below key market segments:

Breakup by Product:

Instruments
Reagents

Breakup by Technology:

Helicase-Dependent Amplification (HDA)
Nicking Enzyme Amplification Reaction (NEAR)
Loop-Mediated Isothermal Amplification (LAMP)
Strand Displacement Amplification (SDA)
Nucleic Acid Sequence-Based Amplification (NASBA)
Transcription Mediated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Others

Breakup by Application:

Infectious Disease Diagnosis
Hepatitis
CT/NG
HIV
Influenza
Others
Blood Screening
Others

Breakup by End-User:

Hospitals
Diagnostic Laboratories
Research Laboratories
Others

Breakup by Region Segment:

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

Browse related reports:

Indian Vaccine Market Report: https://www.imarcgroup.com/indian-vaccine-market

Indian Diabetes Market Report: https://www.imarcgroup.com/india-diabetes

GCC Generic Drug Market: https://www.imarcgroup.com/gcc-generic-drug-market

GCC Generic Injectables Market: https://www.imarcgroup.com/gcc-generic-injectables-market

India Animal Health Market: https://www.imarcgroup.com/india-animal-health-market

Contact US:

IMARC Group

30 N Gould St,

Ste R Sheridan, WY 82801,
USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.